{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,22]],"date-time":"2026-02-22T01:46:51Z","timestamp":1771724811692,"version":"3.50.1"},"reference-count":57,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","maturitas.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Maturitas"],"published-print":{"date-parts":[[2012,4]]},"DOI":"10.1016\/j.maturitas.2012.01.007","type":"journal-article","created":{"date-parts":[[2012,2,23]],"date-time":"2012-02-23T22:06:49Z","timestamp":1330034809000},"page":"345-353","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"title":["The pharmacology of nomegestrol acetate"],"prefix":"10.1016","volume":"71","author":[{"given":"Xiangyan","family":"Ruan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harald","family":"Seeger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alfred O.","family":"Mueck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.maturitas.2012.01.007_bib0005","doi-asserted-by":"crossref","first-page":"865","DOI":"10.2165\/00002512-200421130-00004","article-title":"New progestogens: a review of their effects in perimenopausal and postmenopausal women","volume":"21","author":"Sitruk-Ware","year":"2004","journal-title":"Drugs Aging"},{"key":"10.1016\/j.maturitas.2012.01.007_bib0010","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/0010-7824(93)90112-K","article-title":"One year contraception with a single subdermal implant containing nomegestrol acetate (Uniplant)","volume":"47","author":"Coutinho","year":"1993","journal-title":"Contraception"},{"key":"10.1016\/j.maturitas.2012.01.007_bib0015","doi-asserted-by":"crossref","DOI":"10.1016\/S0010-7824(96)00180-1","article-title":"The use of nomegestrol acetate subdermal contraceptive implant, Uniplant, during lactation","volume":"54","author":"Abdel-Aleem","year":"1996","journal-title":"Contraception"},{"key":"10.1016\/j.maturitas.2012.01.007_bib0020","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/0378-5122(89)90117-5","article-title":"The effects of the addition of nomegestrol acetate to postmenopausal oestrogen therapy","volume":"11","author":"Fraser","year":"1989","journal-title":"Maturitas"},{"key":"10.1016\/j.maturitas.2012.01.007_bib0025","first-page":"70","article-title":"Cardiovascular risk factors and combined estrogen-progestin replacement therapy: a placebo-controlled study with nomegestrol acetate and estradiol","volume":"45","author":"Conard","year":"1995","journal-title":"Fertil Steril"},{"key":"10.1016\/j.maturitas.2012.01.007_bib0030","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/S0149-2918(98)80072-6","article-title":"Continuous hormone replacement therapy for menopause combining nomegestrol acetate and gel, patch, or oral estrogen: a comparison of amenorrhea rates","volume":"20","author":"Blanc","year":"1998","journal-title":"Clin Ther"},{"key":"10.1016\/j.maturitas.2012.01.007_bib0035","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1055\/s-2004-814460","article-title":"Nomegestrol acetate: a progestin that deserves recognition","volume":"36","author":"Shields-Botella","year":"2004","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.maturitas.2012.01.007_bib0040","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.steroids.2011.02.002","article-title":"Nomegestrol acetate, a novel progestogen for oral contraception","volume":"76","author":"Mueck","year":"2011","journal-title":"Steroids"},{"key":"10.1016\/j.maturitas.2012.01.007_bib0045","doi-asserted-by":"crossref","first-page":"430","DOI":"10.3109\/13625187.2011.614029","article-title":"Efficacy and tolerability of a monophasic combined oral contraceptive containing nomegestrol acetate and 17\u03b2-oestradiol in a 24\/4 regimen, in comparison to an oral contraceptive containing ethinylestradiol and drospirenone in a 21\/7 regimen","volume":"16","author":"Mansour","year":"2011","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.maturitas.2012.01.007_bib0050","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.maturitas.2012.01.018","article-title":"The Pharmacology of dienogest","volume":"71","author":"Ruan","year":"2012","journal-title":"Maturitas"},{"key":"10.1016\/j.maturitas.2012.01.007_bib0055","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.contraception.2009.08.010","article-title":"Review of clinical experience with estradiol in combined oral contraceptives","volume":"81","author":"Fruzzetti","year":"2010","journal-title":"Contraception"},{"key":"10.1016\/j.maturitas.2012.01.007_bib0060","first-page":"3","article-title":"The long road to the pill with (natural) estradiol","volume":"14","author":"Mueck","year":"2009","journal-title":"Gynaecol Forum"},{"key":"10.1016\/j.maturitas.2012.01.007_bib0065","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.maturitas.2008.11.011","article-title":"Pharmacological profile of progestins","volume":"61","author":"Sitruk-Ware","year":"2008","journal-title":"Maturitas"},{"key":"10.1016\/j.maturitas.2012.01.007_bib0070","doi-asserted-by":"crossref","first-page":"541","DOI":"10.2165\/11532130-000000000-00000","article-title":"Nomegestrol acetate: pharmacology, safety profile and therapeutic efficacy","volume":"70","author":"Bello","year":"2010","journal-title":"Drugs"},{"key":"10.1016\/j.maturitas.2012.01.007_bib0075","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/0960-0760(93)90105-6","article-title":"Enzyme immunoassay for nomegestrol acetate in human plasma","volume":"46","author":"Ezan","year":"1993","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/j.maturitas.2012.01.007_bib0080","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.maturitas.2008.11.013","article-title":"Classification and pharmacology of progestins","volume":"61","author":"Schindler","year":"2003","journal-title":"Maturitas"},{"key":"10.1016\/j.maturitas.2012.01.007_bib0085","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/0039-128X(91)90055-Z","article-title":"Interaction of [3H]nomegestrol acetate with cytosolic progesterone receptors from the rat uterus","volume":"56","author":"Duc","year":"1991","journal-title":"Steroids"},{"key":"10.1016\/j.maturitas.2012.01.007_bib0090","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/S0022-3565(25)23767-3","article-title":"Regulation of rat uterine steroid receptors by nomegestrol acetate, a new 19-nor-progesterone derivative","volume":"248","author":"Botella","year":"1989","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.maturitas.2012.01.007_bib0095","first-page":"544","article-title":"The cellular mechanism of the antiandrogenic action of nomegestrol acetate, a new 19-nor progestagen, on the rat prostate","volume":"115","author":"Botella","year":"1987","journal-title":"Acta Endocrinol (Copenh)"},{"key":"10.1016\/j.maturitas.2012.01.007_bib0100","first-page":"70","article-title":"Antiandrogenic properties of nomegestrol acetate","volume":"45","author":"Duc","year":"1995","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.maturitas.2012.01.007_bib0105","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/S0022-3565(25)39233-5","article-title":"Extinction of mineralocorticoid effects in 19-norprogesterone derivatives: structure\u2013activity relationships","volume":"243","author":"Paris","year":"1987","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.maturitas.2012.01.007_bib0110","doi-asserted-by":"crossref","first-page":"314","DOI":"10.3109\/13625187.2010.504313","article-title":"Effects of a monophasic combined oral contraceptive containing nomegestrol acetate and 17\u03b2-oestradiol on ovarian function in comparison to a monophasic combined oral contraceptive containing drospirenone and ethinylestradiol","volume":"15","author":"Duijkers","year":"2010","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.maturitas.2012.01.007_bib0115","doi-asserted-by":"crossref","first-page":"444","DOI":"10.3109\/13625187.2011.604450","article-title":"Effects of a monophasic combined oral contraceptive containing nomegestrol acetate and 17\u03b2-oestradiol compared with one containing levonorgestrel and ethinylestradiol on haemostasis, lipids and carbohydrate metabolism","volume":"16","author":"Agren","year":"2011","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.maturitas.2012.01.007_bib0120","doi-asserted-by":"crossref","first-page":"458","DOI":"10.3109\/13625187.2011.614363","article-title":"Effects of a monophasic combined oral contraceptive containing nomegestrol acetate and 17\u03b2-oestradiol in comparison to one containing levonorgestrel and ethinylestradiol on markers of endocrine function","volume":"16","author":"Agren","year":"2011","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.maturitas.2012.01.007_bib0125","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1160\/TH10-05-0327","article-title":"Haemostatic effects of a new combined oral contraceptive, nomegestrol acetate\/17\u03b2-estradiol, compared with those of levonorgestrel\/ethinyl estradiol. A double-blind, randomised study","volume":"105","author":"Gaussem","year":"2011","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.maturitas.2012.01.007_bib0130","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.contraception.2006.07.013","article-title":"Effects of a single Silastic contraceptive implant containing nomegestrol acetate (Uniplant) on endometrial morphology and ovarian function for 1 year","volume":"74","author":"Barbosa","year":"2006","journal-title":"Contraception"},{"key":"10.1016\/j.maturitas.2012.01.007_bib0135","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/S0015-0282(16)58204-1","article-title":"Effects of a single contraceptive silastic implant containing nomegestrol acetate on ovarian function and cervical mucus production during 2 years","volume":"65","author":"Barbosa","year":"1996","journal-title":"Fertil Steril"},{"key":"10.1016\/j.maturitas.2012.01.007_bib0140","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1210\/jcem-52-2-252","article-title":"Influence of endometrial 17 beta-hydroxysteroid dehydrogenase activity on the binding of estradiol to receptors","volume":"52","author":"Gurpide","year":"1981","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.maturitas.2012.01.007_bib0145","first-page":"2093","article-title":"Stromal PRs mediate induction of 17beta-hydroxysteroid dehydrogenase type 2 expression in human endometrial epithelium: a paracrine mechanism for inactivation of E2","volume":"15","author":"Yang","year":"2001","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.maturitas.2012.01.007_bib0150","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1111\/j.1471-0528.1997.tb11458.x","article-title":"Impact of percutaneous oestradiol gels in postmenopausal hormone replacement therapy on clinical symptoms and endometrium","volume":"104","author":"Foidart","year":"1997","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.maturitas.2012.01.007_bib0155","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1111\/j.1471-0528.1987.tb02322.x","article-title":"Effect of nomegestrol acetate, a new 19-nor-progesterone derivative, on pituitary\u2013ovarian function in women","volume":"94","author":"Bazin","year":"1987","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.maturitas.2012.01.007_bib0160","doi-asserted-by":"crossref","first-page":"4191","DOI":"10.1210\/jcem.84.11.6162","article-title":"The antigonadotropic activity of a 19-nor-progesterone derivative is exerted both at the hypothalamic and pituitary levels in women","volume":"84","author":"Couzinet","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.maturitas.2012.01.007_bib0165","doi-asserted-by":"crossref","first-page":"76","DOI":"10.3109\/13625187.2011.554923","article-title":"Inhibition of ovulation by NOMAC\/E2, a novel monophasic oral contraceptive combining nomegestrol acetate and 17\u03b2-oestradiol: a double-blind, randomised, dose-finding pilot study","volume":"16","author":"Chabbert-Buffet","year":"2011","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.maturitas.2012.01.007_bib0170","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1093\/humrep\/der058","article-title":"Comparison of a 24-day and a 21-day pill regimen for the novel combined oral contraceptive, nomegestrol acetate and 17\u03b2-estradiol (NOMAC\/E2): a double-blind, randomized study","volume":"26","author":"Christin-Maitre","year":"2011","journal-title":"Human Reprod"},{"key":"10.1016\/j.maturitas.2012.01.007_bib0175","first-page":"2827","article-title":"Control of sulfatase activity by nomegestrol acetate in normal and cancerous human breast tissues","volume":"25","author":"Chetrite","year":"2005","journal-title":"Anticancer Res"},{"key":"10.1016\/j.maturitas.2012.01.007_bib0180","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jsbmb.2004.11.004","article-title":"Effect of nomegestrol acetate on estrogen biosynthesis and transformation in MCF-7 and T47-D breast cancer cells","volume":"93","author":"Shields-Botella","year":"2005","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/j.maturitas.2012.01.007_bib0185","first-page":"417","article-title":"Nomegestrol acetate is an anti-aromatase agent in human MCF-7aro breast cancer cells","volume":"3","author":"Chetrite","year":"2010","journal-title":"Horm Mol Biol Clin Invest"},{"key":"10.1016\/j.maturitas.2012.01.007_bib0190","first-page":"105","article-title":"Benefits and risks during HRT \u2013 main safety issue breast cancer","volume":"5","author":"Mueck","year":"2011","journal-title":"Horm Mol Biol Clin Invest"},{"key":"10.1016\/j.maturitas.2012.01.007_bib0195","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1038\/bjc.1993.175","article-title":"Norgestrel and gestodene stimulate breast cancer cell growth through an oestrogen receptor mediated mechanism","volume":"67","author":"Catherino","year":"1993","journal-title":"Br J Cancer"},{"key":"10.1016\/j.maturitas.2012.01.007_bib0200","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/0960-0760(94)90170-8","article-title":"Inhibition by nomegestrol acetate and other synthetic progestins on proliferation and progesterone receptor content of T47-D human breast cancer cells","volume":"50","author":"Botella","year":"1994","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/j.maturitas.2012.01.007_bib0205","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jsbmb.2007.02.002","article-title":"Progesterone receptor membrane component 1: an integrative review","volume":"105","author":"Cahill","year":"2007","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/j.maturitas.2012.01.007_bib0210","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1097\/gme.0b013e31820e5ac5","article-title":"The presence of a membrane-bound progesterone receptor sensitizes the estradiol-induced effect on the proliferation of human breast cancer cells","volume":"18","author":"Neubauer","year":"2011","journal-title":"Menopause"},{"key":"10.1016\/j.maturitas.2012.01.007_bib0215","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1097\/gme.0b013e3182260321","article-title":"Can the increase in breast cancer observed in the estrogen plus progestin arm of the Women's Health Initiative trial be explained by progesterone receptor membrane component 1?","volume":"18","author":"Stanczyk","year":"2011","journal-title":"Menopause"},{"key":"10.1016\/j.maturitas.2012.01.007_bib0220","doi-asserted-by":"crossref","unstructured":"Ruan X, Neubauer H, Yang Y, et al. Progestogens and membrane-initiated effects on the proliferation of human breast cancer cells. Climacteric 2012 (in press).","DOI":"10.3109\/13697137.2011.648232"},{"key":"10.1016\/j.maturitas.2012.01.007_bib0225","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/0010-7824(91)90080-Y","article-title":"Effects of nomegestrol acetate (5mg\/d) on hormonal, metabolic and hemostatic parameters in premenopausal women","volume":"44","author":"Basdevant","year":"1991","journal-title":"Contraception"},{"key":"10.1016\/j.maturitas.2012.01.007_bib0230","first-page":"441","article-title":"Effects of nomegestrol acetate on carbohydrate metabolism","volume":"19","author":"Dorangeon","year":"1993","journal-title":"Diabetes Metab"},{"key":"10.1016\/j.maturitas.2012.01.007_bib0235","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1096\/fj.06-6840com","article-title":"Progestins overcome inhibition of platelet aggregation by endothelial cells by down-regulating endothelial NO synthase via glucocorticoid receptors","volume":"21","author":"Zerr-Fouineau","year":"2007","journal-title":"FASEB J"},{"key":"10.1016\/j.maturitas.2012.01.007_bib0240","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1161\/ATVBAHA.108.178004","article-title":"Certain progestins prevent the enhancing effect of 17\u03b2-estradiol on NO-mediated inhibition of platelet aggregation by endothelial cells","volume":"29","author":"Zerr-Fouineau","year":"2009","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.maturitas.2012.01.007_bib0245","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1016\/0735-1097(94)90184-8","article-title":"Effects of hormone replacement therapy on reactivity of atherosclerotic coronary arteries in cynomolgus monkeys","volume":"24","author":"Williams","year":"1994","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.maturitas.2012.01.007_bib0250","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1016\/S0002-9378(98)70149-8","article-title":"Coadministration of nomegestrol acetate does not diminish the beneficial effects of estradiol on coronary artery dilator responses in nonhuman primates (Macaca fascicularis)","volume":"179","author":"Williams","year":"1998","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.maturitas.2012.01.007_bib0255","first-page":"411","article-title":"Biological and clinical safety of nomegestrol acetate administered alone then associated in inverse sequence with transdermal estradiol, in women at risk of dyslipoproteinemia type IIa","volume":"59","author":"Zatarian","year":"1998","journal-title":"Ann Endocrinol (Paris)"},{"key":"10.1016\/j.maturitas.2012.01.007_bib0260","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1161\/CIRCULATIONAHA.106.642280","article-title":"Hormone therapy and venous thromboembolism among postmenopausal women. Impact of the route of estrogen administration and progestogens: the ESTHER Study","volume":"115","author":"Canonico","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.maturitas.2012.01.007_bib0265","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1097\/gme.0b013e3181e102eb","article-title":"Activated protein C resistance among postmenopausal women using transdermal estrogens: importance of the progestogen","volume":"17","author":"Canonico","year":"2010","journal-title":"Menopause"},{"key":"10.1016\/j.maturitas.2012.01.007_bib0270","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1097\/gme.0b013e3181fa264c","article-title":"Exogenous hormones, the risk of venous thromboembolism, and activated protein C resistance. Editorial","volume":"17","author":"Mueck","year":"2010","journal-title":"Menopause"},{"key":"10.1016\/j.maturitas.2012.01.007_bib0275","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/0002-9378(82)90218-6","article-title":"Comparison of pharmacodynamic properties of various estrogen formulations","volume":"144","author":"Mashchak","year":"1982","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.maturitas.2012.01.007_bib0280","series-title":"Sex steroids and the cardiovascular system","first-page":"201","article-title":"Adverse effects of estrogen treatment: natural vs. synthetic estrogens","author":"Kuhl","year":"1998"},{"key":"10.1016\/j.maturitas.2012.01.007_bib0285","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.contraception.2011.01.021","article-title":"Contraceptive failure in the United States","volume":"83","author":"Trussel","year":"2011","journal-title":"Contraception"}],"container-title":["Maturitas"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378512212000187?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378512212000187?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T08:53:25Z","timestamp":1759913605000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378512212000187"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4]]},"references-count":57,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,4]]}},"alternative-id":["S0378512212000187"],"URL":"https:\/\/doi.org\/10.1016\/j.maturitas.2012.01.007","relation":{},"ISSN":["0378-5122"],"issn-type":[{"value":"0378-5122","type":"print"}],"subject":[],"published":{"date-parts":[[2012,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The pharmacology of nomegestrol acetate","name":"articletitle","label":"Article Title"},{"value":"Maturitas","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.maturitas.2012.01.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.maturitas.2012.01.018","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}